68Ga-XACP3

XACP3 radiopharmaceutical · The First Affiliated Hospital of Xiamen University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 68Ga-XACP3, covering 2025-11-21 to 2025-11-21. Get the full timeline:

Most recent: Clinical Trial Update: 68Ga-XACP3 PET/CT in Prostate Cancer [NA]